Tumor cells in bone secrete pre-osteoclast maturing factors, such as parathyroid hormone-related protein, IL-11, and TNF-ɑ, which stimulate osteoblasts to increase RANKL and decrease osteoprotegerin (OPG) production, consequentially leading to bone destruction [49]. Here, PTHLH is linked to neoplasm.